Skip to content
Clinical Trials – home

Clemastine: A Potential Treatment for Multiple Sclerosis and Other Conditions

2 / 4
trials open to patients / all trials
6+
Countries

In short

Clemastine, an antihistamine medication, is being investigated in several clinical trials for its potential remyelinating effects in conditions like multiple sclerosis and optic neuritis. Researchers are exploring whether clemastine can help repair damaged myelin in the central nervous system, potentially improving neurological function and slowing disease progression. These trials aim to assess clemastine's efficacy, safety, and tolerability as a novel therapeutic approach for demyelinating disorders.

At a glance

Drug
Clemastine Fumarate
Primary Conditions Studied
Multiple Sclerosis, Optic Neuritis, Internuclear Ophthalmoparesis
Potential Mechanism
Remyelination of damaged nerve fibers
Main Outcome Measures
Visual Evoked Potentials, MRI measures (Myelin Water Fraction, T1 Relaxation Time), Clinical disability scales
Dosages Tested
Varying by study, e.g. 4-12 mg daily
Treatment Duration
Typically 3-6 months
Study Designs
Randomized, double-blind, placebo-controlled trials
Safety Monitoring
Adverse event tracking, fatigue assessments
Additional Applications
Late-life depression, Williams Syndrome

What is Clemastine?

Clemastine, also known by brand names such as Tavist, Dayhist, and Dayhist Allergy, is a medication that was originally approved by the Food and Drug Administration (FDA) for treating allergies. It belongs to a class of drugs called antihistamines, which help relieve allergy symptoms. However, recent research has shown that clemastine may have potential benefits beyond treating allergies, particularly in neurological conditions like multiple sclerosis (MS).

Potential Uses of Clemastine

While clemastine is not yet FDA-approved for these uses, researchers are investigating its potential in treating several conditions:

  • Multiple Sclerosis (MS): Clemastine is being studied as a potential treatment for various forms of MS, including relapsing-remitting MS, primary progressive MS, and chronic progressive MS.
  • Optic Neuritis: This is an inflammation of the optic nerve that can cause vision loss. Researchers are investigating if clemastine can help repair damage to the optic nerve.
  • Late-life Depression: Some studies are looking at whether clemastine can improve brain function and boost antidepressant response in older adults with depression.
  • Williams Syndrome: This is a rare genetic disorder that affects various parts of the body. Researchers are studying if clemastine can help with neurodevelopmental delays associated with this condition.

How Clemastine Works

In MS and similar conditions, clemastine is thought to work by promoting remyelination. Myelin is a protective coating around nerve fibers in the brain and spinal cord. In MS, this coating is damaged, leading to various symptoms. Clemastine may help by:

  • Promoting Oligodendrocyte Differentiation: Oligodendrocytes are cells that produce myelin. Clemastine may help these cells mature and produce more myelin.
  • Improving White Matter Integrity: White matter in the brain consists largely of myelinated nerve fibers. Researchers are using advanced brain imaging techniques to see if clemastine can improve the structure and function of white matter.

Clinical Trials and Research

Several clinical trials are currently underway to investigate the potential benefits of clemastine:

  • MS and Optic Neuritis: Trials are looking at whether clemastine can improve visual function in people with MS-related optic nerve damage.
  • Brain Imaging Studies: Researchers are using advanced MRI techniques to see if clemastine can improve various measures of brain health in people with MS.
  • Depression in Older Adults: A study is investigating whether clemastine can improve brain function and enhance the effects of antidepressants in older adults with depression.
  • Williams Syndrome: Researchers are studying if clemastine can help improve cognitive, motor, and social skills in children with Williams syndrome.

Potential Side Effects

As with any medication, clemastine may cause side effects. Common side effects of antihistamines like clemastine can include:

  • Drowsiness or sleepiness
  • Dizziness
  • Dry mouth
  • Headache
  • Stomach discomfort

In the clinical trials for MS and other conditions, researchers are carefully monitoring for any side effects, particularly fatigue, as this is already a common symptom in MS.

Other Potential Uses

In addition to the neurological conditions mentioned above, researchers are also investigating clemastine for other potential uses:

  • Cardiovascular Surgery: A study is looking at whether clemastine can help reduce allergic reactions during heart surgery.
  • Cancer Treatment: Researchers are studying whether clemastine can help prevent allergic reactions to certain chemotherapy drugs.

It's important to note that while these studies show promise, clemastine is not yet approved for treating MS or any of these other conditions. Patients should always consult with their healthcare provider before considering any new treatment.

Questions people often ask

Conditions where Clemastine is being studied

Each condition opens its own overview and trial list

Trials with Clemastine

Recruiting trials first

See all 4 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.